The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1361
ISSUE1361
April 4, 2011
Intravenous Acetaminophen (Ofirmev)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Intravenous Acetaminophen (Ofirmev)
April 4, 2011 (Issue: 1361)
The FDA has approved an intravenous (IV) formulation
of acetaminophen (Ofirmev – Cadence) for use in
patients ≥2 years old for management of pain either as
monotherapy (mild to moderate pain) or with an opioid
(moderate to severe pain) and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.